Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy of advanced non-small cell lung cancer. A review.

× No keyword cloud information.

48 in total

1. Clinical studies of vinblastine.

Authors: E FREI; A FRANZINO; B I SHNIDER; G COSTA; J COLSKY; C O BRINDLEY; H HOSLEY; J F HOLLAND; G L GOLD; U JONSSON
Journal: Cancer Chemother Rep Date: 1961-06

2. MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer.

Authors: A P Chahinian; E M Mandel; J F Holland; I S Jaffrey; A S Teirstein
Journal: Cancer Date: 1979-05 Impact factor: 6.860

Review 3. Chemotherapy of metastatic non-small cell bronchogenic carcinoma.

Authors: P C Hoffman; J D Bitran; H M Golomb
Journal: Semin Oncol Date: 1983-03 Impact factor: 4.929

4. Rationale for the use of alternating non-cross-resistant chemotherapy.

Authors: J H Goldie; A J Coldman; G A Gudauskas
Journal: Cancer Treat Rep Date: 1982-03

5. Immediate versus postponed combination chemotherapy (CAMP) for unresectable non-small cell lung cancer: a randomized trial.

Authors: T E Lad; R B Nelson; U Diekamp; L J Kukla; P R Sarma; C S Larson; E T Currie; M S Chawla; T Tichler; P Zawila; W P McGuire
Journal: Cancer Treat Rep Date: 1981 Nov-Dec

6. Phase I and II studies of vindesine.

Authors: M Valdivieso
Journal: Cancer Treat Rev Date: 1980-09 Impact factor: 12.111

7. Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma.

Authors: Y Cormier; D Bergeron; J La Forge; M Lavandier; M Fournier; J Chenard; M Desmeules
Journal: Cancer Date: 1982-09-01 Impact factor: 6.860

8. Combination chemotherapy with cis-diamminedichloroplatinum and vinblastine in advanced non-small cell lung cancer.

Authors: T M Woodcock; M S Blumenreich; S P Richman; T T Kubota; P S Gentile; J C Allegra
Journal: J Clin Oncol Date: 1983-04 Impact factor: 44.544

9. cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.

Authors: J C Britell; R T Eagan; J N Ingle; E T Creagen; J Rubin; S Frytak
Journal: Cancer Treat Rep Date: 1978-08

10. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancer.

Authors: J A Knost; F A Greco; K R Hande; R L Richardson; M F Fer; R K Oldham
Journal: Cancer Treat Rep Date: 1981 Nov-Dec

1 in total

1. Phase II trial of bisantrene in non-small cell lung cancer.

Authors: T P Miller; F R Ahmann; C Mackel; B R Greenberg; D S Alberts
Journal: Invest New Drugs Date: 1985 Impact factor: 3.850

1 in total